Observational studyCancer medicine2019

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States.

Iman Abou Dalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.